Jong‐Wei Lin

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome

Tzung‐Dau Wang, Wen‐Jone Chen, Jong‐Wei Lin et al. · The American Journal of Cardiology · 2004 · 150 citations

Medicine, Endocrinology, Pharmacology +16

Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles

Tzung‐Dau Wang, Wen‐Jone Chen, Jong‐Wei Lin et al. · Atherosclerosis · 2003 · 126 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +11

Domains responsible for the differential targeting of glucose transporter isoforms.

Tomoichiro Asano, Kei‐ichi Takata, Hideki Katagiri et al. · Journal of Biological Chemistry · 1992 · 81 citations · Full text

Life Sciences, Cell Biology, Endocrinology +14

Relation of Improvement in Endothelium-Dependent Flow-Mediated Vasodilation After Rosiglitazone to Changes in Asymmetric Dimethylarginine, Endothelin-1, and C-Reactive Protein in Nondiabetic Patients With the Metabolic Syndrome

Tzung‐Dau Wang, Wen‐Jone Chen, Wern‐Cherng Cheng et al. · The American Journal of Cardiology · 2006 · 72 citations

Medicine, Pharmacology, Physiology +17

Replacement of intracellular C-terminal domain of GLUT1 glucose transporter with that of GLUT2 increases Vmax and Km of transport activity.

Hideki Katagiri, Tomoichiro Asano, Hisamitsu Ishihara et al. · Journal of Biological Chemistry · 1992 · 60 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14